Home > Category > > Standard > Ganglioside GM3 (18, 2)

Ganglioside GM3 (18, 2)

Nagara

Catalog No：GM300101 CAS No.：11545-33-6 MDLNo： Brand:Nagara purity： 特性： Purpose:

Share

Size	Availability	Price(USD)
0.2MG	-	Inquiry

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	Ganglioside GM3 (18, 2)
CAS	11545-33-6
Storage condition	F

Related literature

Sorry, there is no relevant literature

Related

Vitisin A

Disialyllactose sodium salt ≧99%　(TLC)

Disialyllactose sodium salt ≧99%　(TLC)

6’-Sialyllactose sodium salt (synthetic)

6’-Sialyllactose sodium salt (synthetic)

6’-Sialyllactose sodium salt (synthetic)

6’-Sialyllactose sodium salt (synthetic)

3’-Sialyllactose sodium salt (synthetic)

3’-Sialyllactose sodium salt (synthetic)

3’-Sialyllactose sodium salt (synthetic)

3’-Sialyllactose sodium salt (synthetic)

6’-Sialyllactose sodium salt, from human milk

6’-Sialyllactose sodium salt, from human milk

6’-Sialyllactose sodium salt, from human milk

6’-Sialyllactose sodium salt, from human milk

3’-Sialyllactose sodium salt, from human milk

3’-Sialyllactose sodium salt, from human milk

3’-Sialyllactose sodium salt, from human milk

3’-Sialyllactose sodium salt, from human milk

History

Ganglioside GM3 (18, 2)

Ganglioside GM3 (18, 2)

4-(2,6-Diisopropoxyphenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphole

4-(2,6-Diisopropoxyphenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphole

NA ≥95%,99%e.e.

(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-2-naphthalenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

NA ≥98%,99%e.e.

ANTI-MO KLRG1 2F1 AF488

ANTI-MO KLRG1 2F1 AF488

(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-bis[2,4,6-trisisopropylphenyl]-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

NA ≥98%,99%e.e.

1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-bis(4-methylphenyl)-phosphine

1,1'-[(1R)-6,6'-Dimethoxy[1,1'-biphenyl]-2,2'-diyl]bis[1,1-bis(4-methylphenyl)-phosphine

133545-24-1 ≥98%,99%e.e.

(2S,3S)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2-ethyl-2,3-dihydro-1,3-benzoxaphosphole

(2S,3S)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2-ethyl-2,3-dihydro-1,3-benzoxaphosphole

1884594-03-9 ≥95%,99%e.e.

(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin

NA ≥98%,99%e.e.